AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Cytokines and CD80 Enhance Immunogenicity of Cell Vaccine.

Women's Health Weekly

| February 01, 2001 | Henderson, CW | COPYRIGHT 2001 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2001 FEB 1 - (NewsRx.com) -- Tumor cells genetically altered to express CD80 and certain interleukins (IL) can be used to enhance the efficacy of tumor vaccines against cervical cancer, according to a recent study.

"Tumor cells fail to activate specific cytotoxic T lymphocytes due to lack of co-stimulatory molecules, e.g., CD80 (B7.1)," stated A.M. Kaufmann and colleagues, Loyola University, Illinois. "We were able to render cervical carcinoma cells immunogenic by introduction of the CD80 gene into the tumor cells. In order to enhance the efficiency of T-cell activation we investigated whether addition of interleukins would augment immunostimulation by CD80."

Kaufmann et al. published the results of their study in the journal Immunobiology ("Comparison of cytokines and CD80 for enhancement of immunogenicity of cervical cancer cells," Immunobiol, 2000;202(4):339-352).

The researchers stimulated allogeneic T cells with CD80-expressing HeLa cells or CaSki cells. This was done in the absence or presence of IL-2, IL-7, IL-12, or the interleukins in several different combinations.

Next, they evaluated the proliferative response of the T cells. They observed that CD80-transduced HeLa or CaSki cells were capable of inducing a stronger proliferative response in allogeneic T cells than parental or mock transfected control cells.

Any of the three tested interleukins enhanced the proliferative response of allogeneic T cells to CD80-expressing tumor cells. They reported that IL-2 or ...

Related articles from newspapers, magazines, journals, and more
Dendritic cells that capture dead tumor cells secrete IL-12 and TNF-alpha.
Newspaper article from: Biotech Week December 29, 2004 700+ words
...cells that capture dead tumor cells secrete IL-12 and TNF-alpha...that capture dead tumor cells (Mo-DCs-Tum) secrete interleukin 12 (IL-12) and tumor necrosis...cells that capture dead tumor cells secrete IL-12 and TNF-alpha...
Interleukin-12 boosts immune response to autologous tumor cells.
Newspaper article from: Immunotherapy Weekly January 22, 2003 700+ words
...immune activity against autologous tumor cells." According to a report by M.A...were stimulated by interleukin-12 (IL-12; 100 IU/ml) and IL-2 (1,000 IU/ml) without contact with tumor cells for 36 hours. Specific cytotoxic...
Stressed apoptotic tumor cells stimulate dendritic cells and induce cytotoxic T...
Newspaper article from: Cancer Weekly January 28, 2003 700+ words
...that stressed apoptotic tumor cells are more immunogenic in...nonstressed apoptotic tumor cells, we analyzed the responses...secrete interleukin-12 (IL-12) and in enhancing...that stressed apoptotic tumor cells are capable of providing...
Stressed apoptotic tumor cells stimulate dendritic cells and induce cytotoxic T...
Newspaper article from: Vaccine Weekly January 29, 2003 700+ words
...that stressed apoptotic tumor cells are more immunogenic in...nonstressed apoptotic tumor cells, we analyzed the responses...secrete interleukin-12 (IL-12) and in enhancing...that stressed apoptotic tumor cells are capable of providing...
Adenoviral transduction of tumor cells induces apoptosis in cocultured T cells.
Newspaper article from: Cancer Weekly January 7, 2003 700+ words
...with adenovirally transduced tumor cells. "Interestingly, and in...cells were cocultured with tumor cells adenovirally transduced to express IL-7 and CD80, both molecules...Adenoviral transduction of tumor cells induces apoptosis in co...
Technology blocks gene to increase immune response against brain tumor cells.
Newspaper article from: Gene Therapy Weekly June 17, 2004 700+ words
...They combine in the laboratory tumor cells that have been surgically removed...occurring protein, interleukin 12 (IL-12), interacting with dendritic...Th1 cells. Interleukin 10 (IL-10) inhibits the production of IL-12. "Interleukin 10 is a...
Stem cell factor gene-modified natural killer cells overwhelm tumor cells.
Newspaper article from: Drug Week June 25, 2004 700+ words
...natural killer cells overwhelm tumor cells. According to recent research...rapidly in response to interleukin (IL)-2 or IL-15 stimulation; the cumulative...against a broad range of target tumor cells than their parent NK-92 cells...
T cell clones eliminate antigen-positive malignant melanoma tumor cells.
Newspaper article from: Cancer Weekly February 11, 2003 700+ words
...administered, the first without IL-2 and subsequent infusions with low-dose IL-2 (at 0.25, 0.50, and...vivo in response to low-dose IL-2, preferentially localize...elimination of antigen-positive tumor cells, regression of individual metastases...
For more facts and information, see all results

Source: HighBeam Research, Cytokines and CD80 Enhance Immunogenicity of Cell Vaccine.

©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA